Glenmark Pharmaceuticals Inc., USA has recalled 31,224 tubes of Clotrimazole and Betamethasone Dipropionate Cream USP (1%/0.05%), a prescription topical medication. The recall was initiated after receiving complaints that the cream had a liquidy texture, indicating the product has been affected by temperature abuse during the supply chain or storage. This texture change means the medication may not have the correct consistency or stability intended for effective treatment. Consumers who have this prescription cream should check their tube for the affected lot number and contact their healthcare provider or pharmacist.
The liquidy texture of the cream suggests the product was exposed to temperatures outside of its required storage range, which can compromise the medication's physical stability and potentially its effectiveness in treating skin conditions.
Healthcare consultation and pharmacy refund.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.